Related references
Note: Only part of the references are listed.Enhanced response to PD-L1 silencing by modulation of TME via balancing glucose metabolism and robust co-delivery of siRNA/Resveratrol with dual-responsive polyplexes
Li Jia et al.
BIOMATERIALS (2021)
CD47-mediated DTIC-loaded chitosan oligosaccharide-grafted nGO for synergistic chemo-photothermal therapy against malignant melanoma
Xiaozhen Zhan et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment
Youyou Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification
Wencheng Wu et al.
ADVANCED MATERIALS (2020)
Effective Phototheranostics of Brain Tumor Assisted by Near-Infrared-II Light-Responsive Semiconducting Polymer Nanoparticles
Guohua Wen et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Polydopamine-coated nucleic acid nanogel for siRNA-mediated low-temperature photothermal therapy
Fei Ding et al.
BIOMATERIALS (2020)
Constructing Cu7S4@SiO2/DOX Multifunctional Nanoplatforms for Synergistic Photothermal-Chemotherapy on Melanoma Tumors
Leilei Zhang et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
Yijing Liu et al.
CHEMICAL SOCIETY REVIEWS (2019)
Interaction of biologically relevant proteins with ZnO nanomaterials: A confounding factor for in vitro toxicity endpoints
Emilie Da Silva et al.
TOXICOLOGY IN VITRO (2019)
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
Gang Cheng et al.
NATURE COMMUNICATIONS (2019)
Antitumor Effect of Lonidamine-Polypeptide-Peptide Nanoparticles in Breast Cancer Models
Ifat Cohen-Erez et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo/photothermal therapy of breast cancer
Bin Liu et al.
BIOMATERIALS (2019)
miR-625-5p/PKM2 negatively regulates melanoma glycolysis state
Hailin Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy
Xiao Lin et al.
BIOMATERIALS SCIENCE (2019)
Hypoxia-Modified Cancer Cell Metabolism
Wafaa Al Tameemi et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway
Dhiraj Kumar et al.
BMC CANCER (2018)
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
Tina Cascone et al.
CELL METABOLISM (2018)
Organic molecule-based photothermal agents: an expanding photothermal therapy universe
Hyo Sung Jung et al.
CHEMICAL SOCIETY REVIEWS (2018)
Tumour-homing chimeric polypeptide-conjugated polypyrrole nanoparticles for imaging-guided synergistic photothermal and chemical therapy of cancer
Mengmeng Sun et al.
THERANOSTICS (2018)
Pleiotropic effects of moonlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in cancer progression, invasiveness, and metastases
Michael A. Sirover
CANCER AND METASTASIS REVIEWS (2018)
Zinc Metabolism and Metallothioneins
Abdulkerim Kasim Baltaci et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2018)
Dinitrophenyl hapten with laser immunotherapy for advanced malignant melanoma: A clinical study
Dian-Jun Chen et al.
ONCOLOGY LETTERS (2017)
Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells
Te-Chih Cheng et al.
MARINE DRUGS (2017)
HIF1/2α mediates hypoxia-induced LDHA expression in human pancreatic cancer cells
Xin-gang Cui et al.
ONCOTARGET (2017)
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
Lili Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines
Ismael Riquelme et al.
PATHOLOGY & ONCOLOGY RESEARCH (2016)
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
Qian Chen et al.
NATURE COMMUNICATIONS (2016)
Perfluoropentane-Encapsulated Hollow Mesoporous Prussian Blue Nanocubes for Activated Ultrasound Imaging and Photothermal Therapy of Cancer
Xiaoqing Jia et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Antioxidants can increase melanoma metastasis in mice
Kristell Le Gal et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer
Lijia Jing et al.
BIOMATERIALS (2014)
Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
Krushna C. Patra et al.
CANCER CELL (2013)
High expression of glycolytic and pigment proteins is associated with worse clinical outcome in stage III melanoma
Johan Falkenius et al.
MELANOMA RESEARCH (2013)
Zinc Oxide Nanoparticles Interfere With Zinc Ion Homeostasis to Cause Cytotoxicity
Yi-Yun Kao et al.
TOXICOLOGICAL SCIENCES (2012)
The role of hypoxia inducible factor-1α in the increased MMP-2 and MMP-9 production by human monocytes exposed to nickel nanoparticles
Rong Wan et al.
NANOTOXICOLOGY (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Dual purpose Prussian blue nanoparticles for cellular imaging and drug delivery: a new generation of T-1-weighted MRI contrast and small molecule delivery agents
Mohammadreza Shokouhimehr et al.
JOURNAL OF MATERIALS CHEMISTRY (2010)
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
Amar J. Majmundar et al.
MOLECULAR CELL (2010)
Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-β-dependent mechanisms
Bryan L. Copple
LIVER INTERNATIONAL (2010)
Regulation of Membrane-Type 4 Matrix Metalloproteinase by SLUG Contributes to Hypoxia-Mediated Metastasis
Chi-Hung Huang et al.
NEOPLASIA (2009)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Zinc as an anti-tumor agent in prostate cancer and in other cancers
Renty B. Franklin et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Cytotoxic effect of zinc-citrate compound on choriocarcinoma cell lines
S. N. Bae et al.
PLACENTA (2007)
Antiproliferative and apoptotic effects of zinc-citrate compound (CIZAR®) on human epithelial ovarian cancer cell line, OVCAR-3
Seog Nyeon Bae et al.
GYNECOLOGIC ONCOLOGY (2006)
Knockdown of hypoxia-inducible factor-1α in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate
J Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Regulation of the multidrug resistance transporter P-glycoprotein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species
M Wartenberg et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Hypoxia-inducible factor (HIF-1)α:: its protein stability and biological functions
JW Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2004)
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function
JE Wilson
JOURNAL OF EXPERIMENTAL BIOLOGY (2003)
Zinc inhibition of cellular energy production: implications for mitochondria and neurodegeneration
KE Dineley et al.
JOURNAL OF NEUROCHEMISTRY (2003)